by Lui Franciosi | Apr 28, 2016 | News
April 28, 2016, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt:2VP) is pleased to announce that it has hired local intellectual property law firm Oyen Wiggs Green & Mutala LLP to oversee the patenting of its new...
by Lui Franciosi | Apr 26, 2016 | News
April 26, 2016, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt:2VP) announces that further to its news releases dated March 8, 2016 and March 30, 2016, it has completed the first tranche of its non-brokered private...
by Lui Franciosi | Apr 19, 2016 | News
April 19, 2016, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions such as chronic pain, emesis...
by Lui Franciosi | Apr 13, 2016 | News
April 13th, 2016, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions such as chronic pain, emesis...
by Lui Franciosi | Apr 7, 2016 | News
April 7th, 2016, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) is pleased to announce that Cannevert Therapeutics Ltd. has delivered its first quarterly scientific progress report. The report outlines the...
